The GT0918 (Proxalutamide tablets) project has obtained clinical trials permission for prostate cancer indications in China and the United States, and phase I clinical trials have been launched in China
- Categories:The development course
- Author:
- Origin:
- Time of issue:2015-03-15 10:42
- Views:
(Summary description)
The GT0918 (Proxalutamide tablets) project has obtained clinical trials permission for prostate cancer indications in China and the United States, and phase I clinical trials have been launched in China
(Summary description)
- Categories:The development course
- Author:
- Origin:
- Time of issue:2015-03-15 10:42
- Views:
Information
The phase I/II clinical trials of GT0918 (Proxalutamide tablets) project for prostate cancer indications have been launched in the United States
The Group has obtained Series B investment of approximately USD10 million
The GT0918 (Proxalutamide tablets) project has obtained clinical trials permission for prostate cancer indications in China and the United States, and phase I clinical trials have been launched in China
Scan the QR code to read on your phone